Bellerophon Therapeutics, Inc

NanoInk Imaging Inc., a spin-out of Rutgers University, specializes in developing innovative optical imaging technology that utilizes targeted nanoprobes emitting short-wave infrared (SWIR) light. This cutting-edge technology enhances tissue transparency and illumination, allowing for precise molecular targeting of cell surface markers. The company's primary applications focus on pre-clinical drug discovery, providing detailed imaging of tumors and their micro-environment in small animal models, and improving cancer surgery by enabling real-time visualization of tumor margins to minimize the need for repeat procedures. Generated from the website

MetasTx LLC is a clinical research company focused on developing innovative treatments for cancers that have a tendency to spread. With a commitment to scientific advancement, the company is dedicated to overcoming challenges in cancer treatment through rigorous research and due diligence. Located in Pittsburgh, PA, MetasTx LLC emphasizes a strategic approach to its scientific endeavors, comprising a knowledgeable team and a well-structured pipeline of research initiatives. The company aims to contribute significantly to the future of oncology by leveraging its scientific advantages in the battle against metastatic cancers. Generated from the website

Mallinckrodt PLC is a pharmaceutical company based in Bedminster, NJ that specializes in developing and manufacturing a range of medical products. With a focus on healthcare solutions, Mallinckrodt PLC is dedicated to improving patient outcomes through innovative research and development initiatives. Generated from their business information